Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Clayman

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Acta Oto-Rhino-Laryngologica Belgica|January 15, 2000
Developing gene therapy for head and neck cancer communicating bench to bedsideG L Clayman
Seminars in Oncology|August 22, 2000
The current status of gene therapyG L Clayman
Head & Neck|November 1, 1995
Gene therapy for head and neck cancerG L Clayman
Archives of Otolaryngology--Head & Neck Surgery|August 2, 2000
Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinomaT Nakashima, G L Clayman
Current Oncology Reports|December 21, 2000
Local delivery for gene therapyG L Clayman, L Dreiling
Hematology/Oncology Clinics of North America|September 24, 1999
Injectable modalities as local and regional strategies for head and neck cancerG L Clayman, L K Dreiling
Cancer Research|December 16, 2000
Isolation of a peptide for targeted drug delivery into human head and neck solid tumorsF D Hong, G L Clayman
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 1, 1989
Complex odontoma of the maxillary sinus with a complete dentitionG L Clayman, L J Marentette
Archives of Otolaryngology--Head & Neck Surgery|April 3, 1998
Selective neck dissection of anatomically appropriate levels is as efficacious as modified radical neck dissection for elective treatment of the clinically negatice neck in patients with squamous cell carcinoma of the upper respiratory and digestive tractsG L Clayman, D K Frank
Current Opinion in Oncology|May 1, 1996
Gene therapy for head and neck cancerR L Breau, G L Clayman
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Acta Oto-Rhino-Laryngologica Belgica|January 15, 2000
Developing gene therapy for head and neck cancer communicating bench to bedsideG L Clayman
Seminars in Oncology|August 22, 2000
The current status of gene therapyG L Clayman
Head & Neck|November 1, 1995
Gene therapy for head and neck cancerG L Clayman
Archives of Otolaryngology--Head & Neck Surgery|August 2, 2000
Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinomaT Nakashima, G L Clayman
Current Oncology Reports|December 21, 2000
Local delivery for gene therapyG L Clayman, L Dreiling
Hematology/Oncology Clinics of North America|September 24, 1999
Injectable modalities as local and regional strategies for head and neck cancerG L Clayman, L K Dreiling
Cancer Research|December 16, 2000
Isolation of a peptide for targeted drug delivery into human head and neck solid tumorsF D Hong, G L Clayman
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 1, 1989
Complex odontoma of the maxillary sinus with a complete dentitionG L Clayman, L J Marentette
Archives of Otolaryngology--Head & Neck Surgery|April 3, 1998
Selective neck dissection of anatomically appropriate levels is as efficacious as modified radical neck dissection for elective treatment of the clinically negatice neck in patients with squamous cell carcinoma of the upper respiratory and digestive tractsG L Clayman, D K Frank
Current Opinion in Oncology|May 1, 1996
Gene therapy for head and neck cancerR L Breau, G L Clayman
Pageof 10